The Royal Pharmaceutical Society (RPS) has awarded four new Honorary Fellowships.
William Charman, dean of the Faculty of Pharmacy and Pharmaceutical Sciences and director of the Monash Institute of Pharmaceutical Science (MIPS) at Monash University in Melbourne, Australia, was nominated as “one of the most important and influential pharmacists and pharmaceutical scientists worldwide”. Charman has “worked with conviction for better global education in pharmacy, and is an advocate of the Royal Pharmaceutical Society across important global platforms”.
Stewart Adams, now retired, was nominated for jointly leading the team that discovered and developed ibuprofen. Adams, working with John Nicholson, invented ibuprofen while trying to develop a new non-inflammatory medicine for rheumatoid arthritis. The pair synthesised and tested hundreds of compounds. In 1969, sixteen years after their research began, ibuprofen was approved by UK health authorities in the UK as a treatment for rheumatic diseases.
Adams has been reported as saying that he tested the newly created painkiller on his own hangover ahead of a conference speech. In 1987, Adams was awarded an Order of the British Empire (OBE) for his work.
David G Taylor, emeritus professor of pharmaceutical and public health policy at the School of Pharmacy, University College London, was nominated for his collaboration with the International Pharmaceutical Federation (FIP) on the global evolution of pharmacy, his work on the Medicines Waste project with the University of York and his work with Boots on a series of pharmacy-wide public health projects.
Sam Salek, chair of pharmacoepidemiology at the Department of Pharmacy, Pharmacology and Postgraduate Medicine at the University of Hertfordshire, was nominated for “continued excellence in clinical pharmacy education and research, much of which has influenced the practice of pharmacy across the UK and Europe”.
To receive an Honorary Fellowship, individuals must be nominated by a member of the Society who sits on the Assembly, Boards, Membership Committee or any of the Society’s governing bodies. The Assembly must be convinced that the individual has:
- attained ‘distinction’ in a particular aspect or aspects pharmacy, or
- have made a special distinguishing and distinctive contribution to pharmacy or the RPS, or
- have distinguished themselves in any of the branches of knowledge referred to in the objects of the Society, or
- are eminent in public life.